Moderna Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Due to inventory build up in the second quarter 2026, Moderna Inc 's inventory turnover ratio sequentially decreased to 7.5 in the second quarter 2026, otherwise the ratio remained above the average, as MRNA's markets remain strong.Moderna Inc 's average inventory processing period in the Jun 30 2026 quarter, has increased to 49 days, from 46 days, in the Mar 31 2026 quarter.

Within Healthcare sector 51 other companies have achieved higher inventory turnover ratio. While inventory turnover ranking remained unchanged in the Second Quarter 2026 compared to previous quarter at no. 374.

MRNA Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Moderna Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MRNA Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	16.67 %	14.06 %	30.77 %	-19.42 %	-39.85 %
Y / Y Cost of Sales Growth	-21.85 %	961.11 %	-38.84 %	-59.73 %	3.48 %
Inventory Turnover Ratio (TTM)	7.5	7.96	4.07	5.65	6.52
MRNA's Total Ranking	# 374	# 374	# 374	# 572	# 173
Average inventory processing period	49	46	90	65	56
Seq. Inventory Growth	91.78 %	-4.58 %	-53.92 %	38.33 %	87.5 %
Seq. Cost of Sales Growth	-90.26 %	111.28 %	118.36 %	73.95 %	32.22 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 4
Healthcare Sector	# 52
Overall Market	# 374

Inventory Turnover Ratio Statistics
High	Average	Low
9.78	5	2.4
(Jun 30 2024)		(Jun 30 2019)

MRNA Company Profile >> Back to MRNA Efficiency Comparisons >> Compare MRNA Inventory Turnover Ratio to its Competitors

Financial Statements
Moderna Inc 's Inventories	$ 280 Millions	Visit MRNA's Balance sheet
Moderna Inc 's Cost of Revenues TTM	$ 1,707 Millions	Visit MRNA's Income Statement
What are MRNA's Sales?		Visit MRNA's Sales by Segment

Other Inventory Turnover Ratios
Moderna Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
MRNA's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for MRNA's Competitors
Inventory Turnover Ratio for MRNA's Suppliers
Inventory Turnover Ratio for MRNA's Customers

You may also want to know
MRNA's Sales Growth Rates	MRNA's Pe Price to earnings ratio	MRNA's Receivables Turnover Ratio	MRNA's Stock Quote
MRNA's Net Income Growth Rates	MRNA's Ps Price to Sales ratio	MRNA's Sales per Employee	MRNA's Asset Turnover Ratio
MRNA's Net Margin	MRNA's Pb Price to Book ratio	MRNA's Financial Strength Ratios	MRNA's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Neuronetics Inc	16.61	$ 78.345 Millions	$ 5 Millions
Rosecliff Acquisition Corp I	14.94	$ 9.597 Millions	$ 1 Millions
Catheter Precision Inc	14.83	$ 1.001 Millions	$ 0 Millions
Agape Atp Corporation	14.52	$ 0.413 Millions	$ 0 Millions
Edap Tms Sa	12.79	$ 62.351 Millions	$ 5 Millions
Earth Science Tech Inc	11.64	$ 8.974 Millions	$ 1 Millions
Infusystem Holdings Inc	10.92	$ 60.985 Millions	$ 6 Millions
Irhythm Holdings Inc	10.79	$ 235.967 Millions	$ 22 Millions
Tarsus Pharmaceuticals Inc	10.20	$ 43.740 Millions	$ 4 Millions
Lantheus Holdings Inc	10.09	$ 619.325 Millions	$ 61 Millions
Sotera Health Company	10.04	$ 547.412 Millions	$ 55 Millions
Natera Inc	9.46	$ 672.186 Millions	$ 71 Millions
Warby Parker Inc	9.27	$ 414.054 Millions	$ 45 Millions
Hims and Hers Health Inc	9.23	$ 814.411 Millions	$ 88 Millions
Polomar Health Services, Inc.	8.80	$ 1.233 Millions	$ 0 Millions
Myriad Genetics Inc	8.31	$ 250.700 Millions	$ 30 Millions
National Vision Holdings Inc	8.26	$ 841.416 Millions	$ 102 Millions
Autolus Therapeutics Plc	8.08	$ 99.009 Millions	$ 12 Millions
The Oncology Institute Inc	8.03	$ 160.655 Millions	$ 20 Millions
Nutriband Inc	7.92	$ 1.082 Millions	$ 0 Millions
Novavax inc	7.61	$ 88.541 Millions	$ 12 Millions
Inogen Inc	7.51	$ 196.617 Millions	$ 26 Millions
Moderna Inc	7.50	$ 1,707.000 Millions	$ 228 Millions
Cardiff Lexington Corporation	7.49	$ 4.042 Millions	$ 1 Millions
Pulse Biosciences Inc	7.45	$ 1.182 Millions	$ 0 Millions
Vanda Pharmaceuticals Inc	7.43	$ 13.506 Millions	$ 2 Millions
Carlsmed Inc	7.42	$ 13.955 Millions	$ 2 Millions
Adaptive Biotechnologies Corporation	7.26	$ 75.254 Millions	$ 10 Millions
Lifemd Inc	7.22	$ 22.284 Millions	$ 3 Millions
Brightspring Health Services Inc	6.35	$ 4,108.953 Millions	$ 647 Millions

Date modified: 2026-08-31T06:04:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.